Grace Therapeutics, Inc.
Biotechnology
Healthcare
GRCE
15.92 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.11
52 week high
4.50
high
3.11
52 week low
0.00
previous Close
3.11
P/E ratio
market cap
34.98 M
div yield
0
net incoming
-3.36 M
-628.62 %
net profit margin
-336200000.00 %
0.00 %
operating incoming
-3.09 M
2.92 %
net change in cash
-2.13 M
-119.21 %
cash on hand
20.01 M
-9.61 %
cost of revenue
2.00 K
0.00 %
top